Evofem Biosciences Inc (EVFM) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes reproductive and contraceptive care products for women. The companys lead product candidate includes Amphora, a non-hormonal vaginal contraceptive gel for the prevention of urogenital chlamydia and gonorrhea in women. Evofem uses proprietary multi-purpose prevention technology vaginal gel to develop product candidates for multiple indications, including contraception; prevention of urogenital transmission of chlamydia and gonorrhea in women, and recurrent bacterial vaginosis. The company concentrates on womens sexual health and reproductive care, contraception, and the prevention of sexually transmitted infections. Evofem is headquartered in San Diego, California, the US.

Evofem Biosciences Inc (EVFM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evofem Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evofem Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Evofem Biosciences Raises USD7.5 Million Venture Financing 11
Evofem Holdings Raises USD20.5 Million in Venture Financing 12
Evofem Raises USD20 Million in Financing Round 13
Partnerships 14
Evofem Enters into Agreement with DKT International 14
Merger 15
Neothetics and Evofem Biosciences Merges 15
Equity Offering 17
Evofem Biosciences Raises USD39.9 Million in Public Offering of Shares 17
Evofem Biosciences Files Registration Statement to Raise up to USD57.5 Million in Public Offering of Shares 19
Evofem Biosciences Files Registration Statement to Raise up to USD122.3 Million in Public Offering of Shares 20
Evofem Raises USD25 Million in Private Placement of Shares 21
Evofem Biosciences Inc - Key Competitors 22
Evofem Biosciences Inc - Key Employees 23
Evofem Biosciences Inc - Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Product News 25
05/11/2017: Neothetics Provides Business Update on Lead Product Candidate LIPO-202 25
Clinical Trials 26
Jun 26, 2017: Neothetics Announces Top-Line Results for Phase 2 Proof-of-Concept Study of LIPO-202 for the Reduction of Submental Subcutaneous Fat 26
Mar 20, 2017: Neothetics Announces Last Subject Enrolled in Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List Of Tables


Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evofem Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evofem Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Evofem Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Evofem Biosciences Raises USD7.5 Million Venture Financing 11
Evofem Holdings Raises USD20.5 Million in Venture Financing 12
Evofem Raises USD20 Million in Financing Round 13
Evofem Enters into Agreement with DKT International 14
Neothetics and Evofem Biosciences Merges 15
Evofem Biosciences Raises USD39.9 Million in Public Offering of Shares 17
Evofem Biosciences Files Registration Statement to Raise up to USD57.5 Million in Public Offering of Shares 19
Evofem Biosciences Files Registration Statement to Raise up to USD122.3 Million in Public Offering of Shares 20
Evofem Raises USD25 Million in Private Placement of Shares 21
Evofem Biosciences Inc, Key Competitors 22
Evofem Biosciences Inc, Key Employees 23

List Of Figures


Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evofem Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

Evofem Biosciences Inc (EVFM) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes reproductive and contraceptive care products for women. The companys lead product candidate includes Amphora, a non-hormonal

USD 250 View Report

Evofem Biosciences Inc (EVFM) - Medical Equipment - Deals and Alliances Profile

Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes reproductive and contraceptive care products for women. The companys lead product candidate includes Amphora, a non-hormonal

USD 250 View Report

Noble Biosciences Inc - Product Pipeline Analysis, 2020 Update

Noble Biosciences Inc (Noble Biosciences) is a manufacturer of collection, transport and preservation systems for the biopsy. The companys products include biopsy swab kits, environmental swab kits, forensic and genetic

USD 750 View Report

Liminal BioSciences Inc (PLI) - Financial and Strategic SWOT Analysis Review

Liminal BioSciences Inc (PLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available